Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

INTRODUCTION: OncotypeDX© Recurrence Score (RS) is a multigene panel used to aid therapeutic decision making in early-stage, estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) breast cancer. AIM: To compare responses to neoadjuvant endocrine therapy (NET) in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142274/
https://www.ncbi.nlm.nih.gov/pubmed/34022714
http://dx.doi.org/10.1016/j.breast.2021.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142274/
https://www.ncbi.nlm.nih.gov/pubmed/34022714
http://dx.doi.org/10.1016/j.breast.2021.04.010

Ejemplares similares